Abstract
Misfolding and aggregation of proteins is a phenomenon central to the pathology of a wide range of currently incurable disorders, in particular Alzheimer’s (AD) and Parkinson’s disease (PD). Oligomeric species forming during the aggregation reactions of amyloid-β peptide in AD and α-synuclein in PD have been identified as major cytotoxins linked to the pathogenesis of these diseases. However, due to their low abundance in aggregation mixtures and high instability and heterogeneity in terms of the number of constituent monomers, they are exceptionally difficult to characterise using most conventional biophysical techniques.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
